Astera Labs cash flow rises as receivables and inventory absorb $347 million
Astera's nine-month operating cash flow increased, even as receivables and inventory required much more cash. Its Q3 product milestone answers a separate question.
Astera Labs is generating more cash while putting more of it to work between making chips and getting paid. That combination deserves attention alongside the growth headline: a bigger business can produce more cash and still demand a larger financial commitment to keep moving.
In its November 3 earnings release, Astera Labs (Nasdaq: ALAB) reported $341.5 million of operating cash flow for the nine months ended September 30, 2026, versus $224.0 million a year earlier. These are unaudited figures in U.S. dollars.
Over those same nine months, the cash-flow statement shows $201.2 million used by changes in accounts receivable and $146.2 million by inventory. Adding the unrounded figures gives $347.4 million, compared with $11.2 million for those two items in the prior-year period.
Keep the time periods straight
Separately, Astera reported third-quarter revenue of $584.9 million, up 154% year over year. The company said its Scorpio switches became its largest product family by revenue during Q3. It did not disclose that family's dollar sales in the release.
Those product and cash disclosures should not be stitched into a claim that Scorpio alone consumed $347 million. The cash movements cover the whole company over nine months; the product ranking describes one quarter.
Receivables represent money customers owe, while inventory represents products and materials held before sale. Growth in those balances can stretch the interval between committing resources and collecting payment. The figures alone do not establish trouble collecting bills or unwanted inventory.
Operating cash flow is also the result after these movements and other adjustments. Subtracting the $347.4 million from the reported $341.5 million again would count the cash use twice.
The useful investor question is how that funding requirement evolves as sales expand. Watch cash collection and inventory alongside revenue in future reports. A strong sales ramp and healthy cash generation can coexist; tracking both shows more than either headline alone.